Skip to main content

Want a detailed portfolio tracker?

Ardelyx (ARDX) P/E (2014 - 2026)

Ardelyx (ARDX) P/E from Jun 30, 2014 to Jul 21, 2026. The TTM Ardelyx (ARDX) P/E is -21.46. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ardelyx (ARDX)

YearP/EChange
2026-21.46-5.42%
2025-22.69-25.18%
2024-30.33-40.83%
2023-51.26+1305.52%
2022-3.65+384.47%
2021-0.75-87.89%
2020-6.22+17.68%
2019-5.28+357.83%
2018-1.15-60.99%
2017-2.96-42.24%
2016-5.12-66.26%
2015-15.18-99.58%
2014-3.60KN/A

Comparison Ardelyx (ARDX) P/E with competitors

Ardelyx (ARDX) P/E is -21.46.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.35%
FGENFibroGen Inc0.24-101.12%
CHRSCoherus Biosciences Inc0.85-103.95%
FBIOFortress Biotech Inc0.95-104.42%
ORMPOramed Pharmaceuticals Inc1.50-107.00%
AGENAgenus Inc3.01-114.02%
INVAInnoviva Inc3.15-114.70%
VXRTVaxart Inc3.55-116.54%
CRMDCorMedix Inc3.63-116.91%
CVACCureVac N.V.4.45-120.71%
GLPGGalapagos NV4.86-122.64%
SRPTSarepta Therapeutics Inc4.88-122.75%
ABEOAbeona Therapeutics Inc5.39-125.10%
ABUSArbutus Biopharma Corp5.60-126.07%
ZVRAZevra Therapeutics Inc5.89-127.43%
SPROSpero Therapeutics Inc6.23-129.02%
CGENCompugen Ltd6.31-129.42%
RIGLRigel Pharmaceuticals6.87-132.02%
SLXNSilexion Therapeutics Corp7.30-133.99%
OMEROmeros Corporation9.26-143.14%
AUPHAurinia Pharmaceuticals Inc9.58-144.66%
PLXProtalix BioTherapeutics Inc10.89-150.74%
ACADAcadia Pharmaceuticals Inc11.73-154.65%
TBPHTheravance Biopharma Inc12.26-157.13%
ADMAAdma Biologics Inc12.42-157.86%
HRMYHarmony Biosciences Holdings Inc13.82-164.39%
SABSSAB Biotherapeutics Inc14.14-165.86%
NAGENiagen Bioscience Inc14.82-169.04%
INCYIncyte Corp15.82-173.72%
REGNRegeneron Pharmaceuticals Inc15.86-173.88%
PBYIPuma Biotechnology Inc17.32-180.68%
CPRXCatalyst Pharmaceuticals Inc17.44-181.25%
EXELExelixis Inc17.54-181.71%
TGTXTG Therapeutics Inc18.97-188.37%
MDXGMimedx Group Inc20.55-195.76%
XOMAXOMA Royalty Corp22.87-206.58%
ARGXArgen X SE24.30-213.21%
CTMXCytomX Therapeutics Inc24.82-215.65%
XOMAOXOMA Royalty Corp25.34-218.09%
HALOHalozyme Therapeutics Inc25.62-219.39%
XOMAPXOMA Royalty Corp25.67-219.60%
VRTXVertex Pharmaceuticals Inc27.99-230.44%
RPRXRoyalty Pharma plc - Class A28.69-233.66%
SLNOSoleno Therapeutics Inc29.02-235.19%
ASNDAscendis Pharma A/S30.09-240.18%
LGNDLigand Pharmaceuticals Inc - Class B37.91-276.64%
APLSApellis Pharmaceuticals Inc39.02-281.81%
BMRNBiomarin Pharmaceutical Inc42.21-296.68%
KRYSKrystal Biotech Inc45.34-311.27%
ONCBeiGene Ltd69.54-424.01%
PHARPharming Group N.V.75.03-449.57%
TECHBio-Techne Corp101.96-575.06%
VCELVericel Corp109.92-612.16%
ALNYAlnylam Pharmaceuticals Inc117.96-649.64%
GMABGenmab140.29-753.66%
TLXTelix Pharmaceuticals Ltd162.15-855.52%
CORTCorcept Therapeutics Inc212.86-1091.77%